The Leonard Wolfson Experimental Neurology Centre (LWENC) is a a new experimental neurology centre, at University College London aimed at the understanding and treatment of neurodegenerative diseases. On the 25th May they are hosting a unique seminar with world class speakers. This event is being live streamed at the following location starting at 9.40am and finishing at 1pm.Watch the Live Stream – 25th May 9.40am 
The live stream will also be available for viewing after the event.
9:40: Welcome and setting the scene, Nick Fox
Genetic discoveries and Queen Square: advances and opportunities, John Hardy
Introduction of keynote speaker, Sarah Tabrizi
10:00: Keynote lecture, Frank Bennett
Dr. Bennett is Senior Vice President of Research at Ionis Pharmaceuticals. He is responsible for preclinical antisense drug discovery and antisense technology research. Dr. Bennett is also the franchise leader for the Neurological Programs at Ionis. He is one of the founding members of the Company. Dr. Bennett has been involved in the development of antisense oligonucleotides as therapeutic agents, including research on the application of oligonucleotides for inflammatory, neurodegenerative diseases and cancer, oligonucleotide delivery, pharmacokinetics and medicinal chemistry. Dr. Bennett has published more than 175 papers in the field of antisense research and development and has more than 150 issued U.S. patents.
11:00: Refreshment Break
11:25: Huntington’s disease, results from the IONIS HTT Rx CS1 study – first HTT lowering clinical trial, Sarah Tabrizi
11:40: Charcot-Marie-Tooth disease type 1A, trials and developing cohorts, Mary Reilly
11:55: Alzheimer’s disease & Familial Alzheimer’s disease, introduction to cohorts, Catherine Mummery
12:10: Challenge of Antisense oligonucleotide therapy for Familial Alzheimer’s disease, Bart de Strooper
12:25: Developing cohorts in Frontotemporal dementia, Jonathan Rohrer
12:40: Developing cohorts in Parkinson’s disease and progressive supranuclear palsy, Huw Morris
12:55: Closing remarks, Mike Hanna
Hosted by Leonard Wolfson Experimental Neurology Centre and UK Dementia Research Institute at UCL.